within Pharmacolibrary.Drugs.ATC.G;

model G03FB01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.97,
    Cl             = 0.5833333333333334,
    adminDuration  = 600,
    adminMass      = 0.0003,
    adminCount     = 1,
    Vd             = 0.0015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.018333333333333333,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Norgestrel and estrogen (commonly as ethinylestradiol) is a combination hormonal contraceptive used for prevention of pregnancy. This combination was widely used in oral contraceptive pills. Norgestrel is a synthetic progestogen and ethinylestradiol is a synthetic estrogen. The combination is approved for use as an oral contraceptive in many countries.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adult women using standard oral contraceptive doses. No direct published sources for 'norgestrel and estrogen' combined PK model were found; parameters are estimated based on published PK studies of individual components.</p><h4>References</h4><ol><li><p>Moreira de Brito, C, et al., &amp; Cercato, C (2021). Pharmacokinetics of oral levonorgestrel and ethinylestradiol in women after Roux-en-Y gastric bypass surgery. <i>Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery</i> 17(4) 673–681. DOI:<a href=&quot;https://doi.org/10.1016/j.soard.2020.12.007&quot;>10.1016/j.soard.2020.12.007</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33547015/&quot;>https://pubmed.ncbi.nlm.nih.gov/33547015</a></p></li><li><p>Wang, X, et al., &amp; Malhotra, BK (2024). Assessment of the Effects of Abrocitinib on the Pharmacokinetics of Probe Substrates of Cytochrome P450 1A2, 2B6 and 2C19 Enzymes and Hormonal Oral Contraceptives in Healthy Individuals. <i>European journal of drug metabolism and pharmacokinetics</i> 49(3) 367–381. DOI:<a href=&quot;https://doi.org/10.1007/s13318-024-00893-5&quot;>10.1007/s13318-024-00893-5</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38554232/&quot;>https://pubmed.ncbi.nlm.nih.gov/38554232</a></p></li><li><p>Devineni, D, et al., &amp; Leung, AT (2007). Pharmacokinetics and pharmacodynamics of a transdermal contraceptive patch and an oral contraceptive. <i>Journal of clinical pharmacology</i> 47(4) 497–509. DOI:<a href=&quot;https://doi.org/10.1177/0091270006297919&quot;>10.1177/0091270006297919</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17389559/&quot;>https://pubmed.ncbi.nlm.nih.gov/17389559</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end G03FB01;
